Healthcare -
Biotechnology - NASDAQ - US
$ 7.54
-5.16 %
$ 63.5 M
Market Cap
-0.54
P/E
KPTI - TOTAL CURRENT LIABILITIES
Total Current Liabilities KPTI - Karyopharm Therapeutics Inc.
92.3 M
LAST VALUE
18.32%
2 YEAR CAGR
14.76%
5 YEAR CAGR
22.32%
10 YEAR CAGR